gene therapy

Bidding war erupts over Dimension’s gene therapy pipeline as Ultragenyx counters Regenxbio deal
Endpoints
Mon, 09/18/17 - 09:26 am
Dimension Therapeutics
Ultragenyx
Regenxbio
gene therapy
R&D
Profit finally in sight for gene therapy specialist Oxford Bio
Yahoo/Reuters
Wed, 08/23/17 - 10:07 pm
gene therapy
Oxford BioMedica
CTL019
Novartis
Pfizer commits $100M for a gene therapies plant in North Carolina
Fierce Pharma
Thu, 08/10/17 - 10:45 am
Pfizer
gene therapy
drug manufacturing
North Carolina
Is This Why bluebird bio Dipped 10.5% in July?
Motley Fool
Wed, 08/9/17 - 09:35 am
Bluebird Bio
gene therapy
bb2121
bluebird bio Pauses During 2017 Data Blitz
Motley Fool
Mon, 08/7/17 - 05:59 pm
Bluebird Bio
gene therapy
earnings
ASH
Spark offers a glimpse of efficacy in first two hemophilia A gene therapy patients
Endpoints
Wed, 08/2/17 - 09:39 am
Spark Therapeutics
hemophilia A
gene therapy
SPK-8011
FDA embraces the first US application for a gene therapy, offering an accelerated test case
Endpoints
Mon, 07/17/17 - 09:59 am
FDA
gene therapy
Spark Therapeutics
Luxturna
RPE65-mediated inherited retinal disease
BioMarin, Spark, raising the stakes for hemophilia
BioPharma Dive
Wed, 07/12/17 - 02:48 pm
Biomarin
Spark Therapeutics
hemophilia
BMN 270
SPK-9001
gene therapy
FDA panel to focus on safety of Novartis gene therapy drug
Yahoo/Reuters
Mon, 07/10/17 - 09:32 am
FDA
advisory panels
Novartis
gene therapy
CAR-T
acute lymphoblastic leukemia
Who will pay for CRISPR?
Stat
Mon, 06/26/17 - 09:43 am
CRISPR
gene therapy
uniQure
Editas
Spark Therapeutics
Bluebird Reports Early Results From Upgraded Gene Therapy
Xconomy
Fri, 06/23/17 - 09:46 am
Bluebird Bio
LentiGlobin
gene therapy
clinical trials
beta-thalassemia
FDA to Clear Path for Drugs Aimed at Cancer-Causing Genes
Bloomberg
Wed, 06/21/17 - 07:42 pm
FDA
gene therapy
tumor-agnostic therapies
cancer
Scott Gottlieb
Sarepta to collaborate with Genethon on DMD gene therapy; Chinese investors pull back on Pluristem investment
Endpoints
Wed, 06/21/17 - 10:57 am
Sarepta Therapeutics
Genethon
Duchenne Muscular Dystrophy
gene therapy
China
Pluristem
5 Trends affecting gene therapy development
BioPharma Dive
Mon, 06/12/17 - 09:35 pm
gene therapy
gene editing
patents
ethics
drug development
Pfizer expands gene therapy effort on hemophilia, bagging rights to a Sangamo drug in a $545M deal
Endpoints
Thu, 05/11/17 - 11:21 am
Pfizer
gene therapy
hemophilia
Sangamo BioSciences
SB-525
hemophilia A
Biotech firm pulls pioneering gene therapy due to no demand
Yahoo/Reuters
Thu, 04/20/17 - 08:56 pm
uniQure
gene therapy
Glybera
Icahn hires on gene therapy legend—and big biotech disruptor—Richard Mulligan as Bristol-Myers rumors simmer
Endpoints
Thu, 03/2/17 - 09:40 am
Carl Icahn
gene therapy
Richard Mulligan
Bristol-Myers Squibb
Why Spark's CEO says 2017 may be a 'historic year' for his gene therapy company
Bizjournals.com
Wed, 02/22/17 - 05:13 pm
gene therapy
Spark Therapeutics
Pharma CEOs
Jeffrey D. Marrazzo
Biotech Renova takes over Janssen's rights to heart failure candidate stresscopin
Fierce Biotech
Tue, 02/7/17 - 10:34 am
Renova Therapeutics
gene therapy
heart failure
Janssen
stresscopin
Sarepta eyes a different approach to Duchenne: gene therapy
Bizjournals.com
Wed, 01/11/17 - 09:57 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
Exondys 51
gene therapy

Pages